The thymus contributes naïve, self MHC reactive, self tolerant T-cells to the peripheral immune system throughout life, albeit with a log-linear decline with age.
Introduction
An important feature of the adaptive immune response is the broad repertoire of Tcell receptor (TCR) specificities (1) .
TCR diversity is generated through rearrangements of TCR alpha (TCR) chain and TCR beta (TCR) chain genes, and subsequent random pairing of  and  chain polypeptides (2) (3) (4) . The TCR delta (TCR) chain locus lies within the TCR chain locus and its excision forms the first step in TCR chain gene rearrangement (5) . One particularly frequent rearrangement occurs between the rec and ψJalpha element recombination sequences. The intervening excised DNA is circularised by the formation of a 'signal joint' forming a DNA episome, termed a signal joint T-cell receptor excision circle (sjTREC).
Approximately 70% of T-cells emerging from the thymus contain one or two sjTRECs (depending on whether one or both TCR loci genes are rearranged) (6) . As these T-cells mature and proliferate their sjTRECs, which are stable (7) and do not divide, are distributed amongst their progeny (8) .
In humans there is no specific phenotypic marker for recent thymic emigrants.
Although thymic imaging can provide information about thymic capacity (9) it is inconvenient, may involve radiation exposure, and does not provide specific functional information. In 1998 Douek et al published data suggesting that the absolute number of TREC molecules measured per microgram (μg) of DNA derived from isolated CD4 + and CD8 + T cells represented a valid biomarker of thymic function (10) . The original semi-quantitative hybridisation assay has since been superseded by assays that use real-time quantitative PCR for absolute TREC quantification but the underlying principle is that the proportion of peripheral blood
T-cells containing a TREC provides an approximation of recent thymic function.
TREC measurements have been presented in a number of different ways. In some methods a TREC standard enables the reporting of the absolute number of TREC molecules per unit number of cells or TREC molecules per μg of DNA within PBMC or T-lymphocytes (11) (12) (13) . In an alternative approach, TREC DNA has been reported relative to genomic DNA within a particular cellular subset (PBMC, T-lymphocytes, naïve T-lymhocytes) (14) and yet others have sorted individual T cell subsets and measured TREC within that subset (15) . The different methods and units used to measure TRECs affect the interpretation and comparison of TREC data.
Additionally, T cell proliferation, T cell death and intra-cellular TREC degradation influence the different assays in distinct ways. In particular, any assay that uses a cellular subset as denominator, whether absolute cell number or DNA content, will be influenced by cell proliferation within that subset as illustrated by Hazenburg (15).
For instance if an assay reports TREC per cell, an increase in circulating Tlymphocytes as a consequence of peripheral division will artificially dilute the assay readout regardless of recent thymic function. As thymic involution occurs a
proportional decline in peripheral blood TREC numbers occurs and a coincident increase in naïve T cell proliferation maintains the size of this T cell compartment (16, 17) . Memory T cells (CD45RO + ) contain few if any detectable TREC (18) .
Numerous mathematical models have been described which attempt, using the available clinical data, to enhance the interpretation of TREC data in the face of these confounding parameters (15, 19, 20) . Recently, several authors have concluded that measuring TREC per millilitre of blood overcomes the problem induced by cellular proliferation in this assay, since the absolute number of TREC molecules, assuming there is not significant specific death of TREC containing T cells, remains independent of total cell number (21, 22 ).
In the current study we describe and evaluate a method which directly quantifies TREC from whole blood, using a modification of the currently well described real time PCR assay. The value generated is TREC/ml and is therefore measured without reference to cellular populations, removing any confounding attributable to cell proliferation. Moreover, it is performed using very small quantities of whole blood (300ul or less) and removes the necessity for separating PBMC and other T cell subsets. The assay is validated and has been tested in a large sample of healthy control children and adults.
Materials & Methods

Samples
Ethical approval for the study was given by the Newcastle & North Tyneside
Research Ethics Committee. 9ml blood samples were obtained from healthy laboratory controls, individuals attending local blood transfusion donation sessions and from healthy children attending the local hospital for simple surgical procedures such as hernia repair, circumcision and correction of strabismus. All samples were collected in to Vacuette EDTA K3 tubes (Greiner Bio-one, Austria) with informed consent from the individual or a parent or guardian.
DNA extraction
DNA was extracted from 300l of whole blood using the Wizard Genomic DNA extraction kit ® (Promega) according to the manufacturer's instructions and stored at 4C until use. Sample purity and quantity was determined by spectrophotometry (Nanodrop® ND-100). other covariates were present. Results were considered significant when p < 0.05.
RESULTS
Direct quantification of TREC per millilitre of whole blood
We devised a mathematical description for the determination of TREC per millilitre of whole blood, where DNA was extracted from a 300μl aliquot of the sample. TREC per ml was derived using equation 1. Calculated vales for TREC/ml were log transformed since the size of the error in individual results (which had a range of 1.5Log 10 ) was proportional to the size of the mean (24) . This also allowed statistical analysis to be performed on normally distributed data. 
All white cells (granulocytes, monocytes, B-cells, NK cells & T-cells) in whole blood
are nucleated and thus in this assay contribute to the total DNA extracted from any sample. Since the number of white cells (WC) varies between individuals the total WC count may alter the sensitivity of TREC measurements. We therefore assessed the relationships between total WC count, lymphocyte count, neutrophil count and WBLogTREC/ml. WC count and subset counts were determined in a clinical laboratory for a small sample of healthy controls. Samples from patients with rheumatological autoimmune diseases who had blood counts available were also included. We showed that WBLogTREC/ml was significantly correlated with lymphocyte count (sum of T cells (60-80%), B cells (12-20 %), NK cells (10-15%)) (r = 0.71; p<0.01). WC count was correlated to a lesser extent, reflecting the lymphocyte content of total WC (approximately one third lymphocytes), (r = 0.38; p <0.05).
Neutrophil count was not correlated with WBLogTREC/ml - Figure II .
Determining assay precision
The precision of any assay to detect the presence or absence of a quantifiable unit is reduced as the limit of detection for the assay is approached. Here, as the number of TREC molecules detected per reaction approaches one, the precision of the assay The coefficient of variation for the real time reaction was calculated by running two standard samples of DNA in 25 separate real time experiments and was 1.93% and 1.49% for each standard sample respectively (data not shown). Thus, the overall experimental coefficient of variation from DNA extraction to TREC determination (variation in DNA extraction multiplied by variation in RQ-PCR of TREC) was 8.7%, range 7.6 -9.8 %.
Comparison of TREC determination from WB derived DNA with that from PBMC and
CD4
+ derived DNA For a given quantity of total DNA analysed, selection of TREC-rich cells increases the probability of detecting a TREC in a PCR. Thus, in 200ng DNA derived from selected T cells the absolute number of TREC will be higher than in 200ng DNA from PBMC which in turn will be higher than in 200ng DNA from WB. We have shown that our assay becomes less reproducible as TREC/reaction approaches 10 ( Figure   III ). However, whereas the use of WB as a template for TREC measurement may reduce assay sensitivity, variable T cell recovery may alter the accuracy of analyses requiring cellular isolation. We therefore quantified TREC from DNA derived from each type of sample in patients known to have values around the limit of detectionelderly patients with rheumatoid arthritis taking disease modifying anti-rheumatic drugs (DMARDs) (26) .
Samples were initially drawn from ten patients (mean age 60.5yrs (range 48-74yrs)) and TREC quantified for each using WB, isolated PBMC and CD4 + T cells. Figure   IV (A) shows that TREC were detected in 8 patients using CD4 + T cell DNA, 6 patients using PBMC DNA and 5 patients using WB DNA. As the frequency of TREC per sample increased (as judged by the TREC content of CD4 + T cells) the likelihood of detecting TREC using both of the other sample types increased, confirming the sensitivity advantage of selecting a TREC-rich subset. However it is notable that in two patients where insufficient CD4 + T cells were recovered, TREC were detected in both using WB DNA and from one using PBMC DNA, emphasising the potential cost of cell isolation in terms of accuracy. The detection of TREC in WB DNA but not in PBMC DNA from the same individual may also reflect stochastic factors as the limit of assay sensitivity is approached.
We then compared TREC values obtained from PBMC and WB DNA to confirm that results from both assays were consistent. We did not compare either with CD4 + T cell DNA since the former two assays will additionally include TREC present in CD8 + T cells. To increase the sample size for this analysis we isolated DNA from a further 6
RA patients. TREC were detected in 10/16 using WB and 11/16 using PBMC DNA.
The correlation coefficient between WB TREC and PBMC TREC values was very strong (r = 0.92; r <0.01) confirming equivalence of the data ( Figure IVB) .
Whole blood TREC per millilitre (WBLogTREC/ml) values are biologically stable over time in healthy individuals
Despite a decline of approximately 1.5 logs over the age span tested, TREC values at any one age in normal healthy individuals are still highly variable (13) . We therefore sought to examine whether biological variation within an individual over time might contribute to this variation. Nine healthy male and female volunteers aged between 22
and 60 had their WBTREC/ml quantified serially over a three month period. We found that WBLogTREC/ml remained stable over this period ( Figure V) . Using the standard deviation about the mean as a summary measure (as described by Matthews et al (27) ) we showed that there was no biological variation above that which could be expected from the known inter-assay variation (p = 0.45), confirming that any biological variation in healthy individuals occurs at a level not detectable by this assay.
WBLogTREC/ml declines with age and varies with gender in healthy individuals
In healthy individuals thymic function is dependent on age. In a cohort of 221 healthy controls ranging in age from new born (cord blood) to 69 we confirmed a decline in the number of TREC per ml of approximately 1.5Log. As Zhang et al found (13) , there is a suggestion of an accelerated decline in thymic function at puberty but it was not possible to confirm this observation because our sample number in this age range was small (n = 4 for 15-20 years) ( Figure VI and Table 1 ). Moreover, samples at this age were all from males. It has previously been shown that males have reduced thymic function compared to age-matched females (28) . Using the whole blood TREC assay we have confirmed this difference and demonstrated that it extends back into childhood ( Figure VII) . The overall age-adjusted mean WBLogTREC/ml for males (n = 113) is 4.378 and for females (n = 106) is 4.573 (p = 0.043). Zhang et al did not
analyse their data on the basis of gender (13) so comparisons cannot be made.
Discussion
We present here a novel modification to the well established and widely used method of measuring thymic function -the 'TREC Assay' (10) -which quantifies TREC per ml directly from very small volumes of peripheral whole blood. As discussed earlier, we and others have concluded that TREC/ml provides a better estimate of the thymic contribution to the peripheral T cell compartment in cross-sectional analyses than TREC per cell, the interpretation of which is complicated by the effects of peripheral cellular division. Whereas under steady state conditions TREC/ml and TREC per 10 We have devised and validated a 'whole blood TREC assay' using a large group of healthy male and female individuals over a seven decade age range for use in both cross sectional and longitudinal studies. Using this assay we have confirmed the described 1.5 Log fold decline in TREC values with normal aging (13) and the small, previously described, increase in thymic function in females when compared with age matched males (28 for example in paediatric studies, and/or where longitudinal information is required.
The lower limit of detection of our assay is higher than that for assays quantifying TREC using selected T cell subsets but is directly comparable with assays using PBMC derived DNA, with the advantage of significantly lower tissue volume requirement and sample processing time. When working at the limit of assay sensitivity the probability of TREC detection could be increased by quantifying TREC from replicate aliquots of individual samples and adjusting the derived values accordingly.
Our assay cannot distinguish between CD4 + and CD8 + contributions to the recent thymic emigrant subset. However, this limitation is common to most thymic function measurements. Sorting peripheral T cell subsets and quantifying TREC within them allows both maturation pathways of recent thymic emigrants to be explored (as we have previously shown (26)) and, where the total T cell count is known, TREC/ml to be calculated. However, this requires large volumes of blood and is less acceptable to In summary, our group has previously validated and published an assay that is designed specifically for the determination of TREC per cell (14) . We now present an assay that directly quantifies TREC/ml from whole blood. The combination of the two assays, alongside appropriate cell surface labelling contributes a set of tools with which thymic reconstitution can be investigated following lymphoablative treatments and in the clinical evaluation of thymic adjuvant therapies.
Figures
Figure I There is a statistically significant difference between the two groups after correcting for age (p = 0.043). The negative correlation with age is maintained in each population. (A single sample (male; TREC/ml -2.58) was removed from this analysis because it was an outlier exerting significant influence on the result when included). Table 1 Mean WBLogTREC/ml for five year cohorts of healthy controls (male and female combined) with descriptive statistics for each cohort. Data corresponds to values presented in Figure V .
